Rishi Anand
Endocrinology, Diabetes & Metabolism · Bensalem, PANPI 1457599300
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $37,500 of the $41,469 with a category attached, or 90.4%. AstraZeneca accounts for 85.3% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2019 at $28,130 and has fallen 99.9% since, to $23 in 2024.
Across 152 payments — averaging $272.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$35K
- Portola Pharmaceuticals, LLC$4K
- Novo Nordisk$442
- Lilly USA, LLC$225
- Companion Medical, Inc.$109
- Xeris Pharmaceuticals, Inc.$106
- plus $789 from 19 others
What the payments were for
- Speaking & faculty fees$37,50090%
- Travel & lodging$1,2853%
- Food & beverage$2,6456%
- Education$380%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 45 | $35,387 |
| Portola Pharmaceuticals, LLC | 3 | $4,410 |
| Novo Nordisk | 32 | $442 |
| Lilly USA, LLC | 17 | $225 |
| Companion Medical, Inc. | 6 | $109 |
| Xeris Pharmaceuticals, Inc. | 6 | $106 |
| Abbott | 4 | $88 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| Shire North American Group Inc | 6 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $78 |
| Boehringer Ingelheim | 3 | $64 |
| Amgen | 4 | $55 |
| Vivus LLC | 3 | $49 |
| Aytu Biopharma, Inc. | 3 | $45 |
| Insulet Corporation | 2 | $42 |
| Antares Pharma, Inc. | 2 | $38 |
| Eisai Inc. | 2 | $30 |
| Lifescan, Inc. | 2 | $27 |
| Tandem Diabetes Care, Inc. | 1 | $23 |
| Valeritas, Inc. | 1 | $20 |
| AbbVie | 1 | $16 |
| Ascensia Diabetes Care US Inc. | 1 | $15 |
| Zealand Pharma US, Inc. | 1 | $15 |
| BD | 1 | $14 |
| Corcept Therapeutics | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$41,469 in reported general payments places this provider in the 85th percentile of 388 endocrinology, diabetes & metabolism providers in Pennsylvania.
See all endocrinology, diabetes & metabolism providers in Pennsylvania →
Other endocrinology, diabetes & metabolism in Bensalem
- Serge JabbourPhiladelphia$1.2M
- Vijay BahlPittsburgh$998K
- Geraldo SaavedraWhitehall$698K
- Jane MayrinPhiladelphia$628K
- Stephan KowalykGreensburg$591K
- Matthew KaneWest Chester$577K
- Intekhab AhmedPhiladelphia$528K
- Swarna VarmaPittsburgh$520K
- James DickeHanover$425K
- Mitchell LazarPhiladelphia$358K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.